Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples